<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:media="http://search.yahoo.com/mrss/" version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>clinical trial phase</title>
		<link>https://biospectrumasia.com/rssfeed/bio-services/clinical%20trial%20phase</link>
		<atom:link href="https://biospectrumasia.com/rssfeed/bio-services/clinical%20trial%20phase" rel="self" type="application/rss+xml" />
		<description>clinical trial phase</description>
					<item>
			<title>Illumina selected to help bring precision medicine into everyday healthcare in Singapore</title>
			<atom:link href="https://biospectrumasia.com/news/100/28634/illumina-selected-to-help-bring-precision-medicine-into-everyday-healthcare-in-singapore.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/100/28634/illumina-selected-to-help-bring-precision-medicine-into-everyday-healthcare-in-singapore.html</link>
			<pubDate>Tue, 03 Nov 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/unnamed-28634.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/100/28634/illumina-selected-to-help-bring-precision-medicine-into-everyday-healthcare-in-singapore.html</guid>
		</item>	
				<item>
			<title>Shionogi and F2G report Phase 3 results for oral antifungal olorofim</title>
			<atom:link href="https://biospectrumasia.com/news/100/28570/shionogi-and-f2g-report-phase-3-results-for-oral-antifungal-olorofim.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/100/28570/shionogi-and-f2g-report-phase-3-results-for-oral-antifungal-olorofim.html</link>
			<pubDate>Thu, 22 Oct 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images-28570.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/100/28570/shionogi-and-f2g-report-phase-3-results-for-oral-antifungal-olorofim.html</guid>
		</item>	
				<item>
			<title>Merck expands rare disease portfolio with $1.3 billion Silence Therapeutics acquisition</title>
			<atom:link href="https://biospectrumasia.com/news/100/28554/merck-expands-rare-disease-portfolio-with-1-3-billion-silence-therapeutics-acquisition.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/100/28554/merck-expands-rare-disease-portfolio-with-1-3-billion-silence-therapeutics-acquisition.html</link>
			<pubDate>Wed, 21 Oct 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/acb81e2cd9f6434b4e9d3664a749b6c0-28554.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/100/28554/merck-expands-rare-disease-portfolio-with-1-3-billion-silence-therapeutics-acquisition.html</guid>
		</item>	
				<item>
			<title>Minoryx and Neuraxpharm complete enrolment in Phase III CALYX trial of leriglitazone</title>
			<atom:link href="https://biospectrumasia.com/news/100/28356/minoryx-and-neuraxpharm-complete-enrolment-in-phase-iii-calyx-trial-of-leriglitazone.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/100/28356/minoryx-and-neuraxpharm-complete-enrolment-in-phase-iii-calyx-trial-of-leriglitazone.html</link>
			<pubDate>Thu, 10 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images-28356.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/100/28356/minoryx-and-neuraxpharm-complete-enrolment-in-phase-iii-calyx-trial-of-leriglitazone.html</guid>
		</item>	
				<item>
			<title>CStone secures China IND approval for EGFR/HER3 bispecific ADC CS5007</title>
			<atom:link href="https://biospectrumasia.com/news/100/28247/cstone-secures-china-ind-approval-for-egfr-her3-bispecific-adc-cs5007.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/100/28247/cstone-secures-china-ind-approval-for-egfr-her3-bispecific-adc-cs5007.html</link>
			<pubDate>Mon, 24 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cstone_pharma-28247.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/100/28247/cstone-secures-china-ind-approval-for-egfr-her3-bispecific-adc-cs5007.html</guid>
		</item>	
				<item>
			<title>Ribo reports positive Phase IIa data for FXI-targeting siRNA vortosiran</title>
			<atom:link href="https://biospectrumasia.com/news/100/28148/ribo-reports-positive-phase-iia-data-for-fxi-targeting-sirna-vortosiran.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/100/28148/ribo-reports-positive-phase-iia-data-for-fxi-targeting-sirna-vortosiran.html</link>
			<pubDate>Tue, 04 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/suzhou_ribo_life_science_co_ltd_logo-28148.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/100/28148/ribo-reports-positive-phase-iia-data-for-fxi-targeting-sirna-vortosiran.html</guid>
		</item>	
				<item>
			<title>Novo Nordisk reports long-term Phase III data for denecimig in haemophilia A</title>
			<atom:link href="https://biospectrumasia.com/news/100/28009/novo-nordisk-reports-long-term-phase-iii-data-for-denecimig-in-haemophilia-a.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/100/28009/novo-nordisk-reports-long-term-phase-iii-data-for-denecimig-in-haemophilia-a.html</link>
			<pubDate>Mon, 13 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images-28009.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/100/28009/novo-nordisk-reports-long-term-phase-iii-data-for-denecimig-in-haemophilia-a.html</guid>
		</item>	
				<item>
			<title>Innovative Molecules doses first patient in Phase 2a herpes trial</title>
			<atom:link href="https://biospectrumasia.com/news/100/27921/innovative-molecules-doses-first-patient-in-phase-2a-herpes-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/100/27921/innovative-molecules-doses-first-patient-in-phase-2a-herpes-trial.html</link>
			<pubDate>Fri, 26 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/innovative_molecules_logo-27921.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/100/27921/innovative-molecules-doses-first-patient-in-phase-2a-herpes-trial.html</guid>
		</item>	
				<item>
			<title>NeuroSense reports Phase 2 biomarker findings for PrimeC in Alzheimer’s disease</title>
			<atom:link href="https://biospectrumasia.com/news/100/27922/neurosense-reports-phase-2-biomarker-findings-for-primec-in-alzheimers-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/100/27922/neurosense-reports-phase-2-biomarker-findings-for-primec-in-alzheimers-disease.html</link>
			<pubDate>Fri, 26 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/logo_positive_horizontal_e1633873048940-27922.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/100/27922/neurosense-reports-phase-2-biomarker-findings-for-primec-in-alzheimers-disease.html</guid>
		</item>	
				<item>
			<title>Innovent doses first patient in Phase III tri-specific antibody trial</title>
			<atom:link href="https://biospectrumasia.com/news/100/27912/innovent-doses-first-patient-in-phase-iii-tri-specific-antibody-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/100/27912/innovent-doses-first-patient-in-phase-iii-tri-specific-antibody-trial.html</link>
			<pubDate>Thu, 25 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/20190319114710011_l-27912.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/100/27912/innovent-doses-first-patient-in-phase-iii-tri-specific-antibody-trial.html</guid>
		</item>	
				<item>
			<title>FedEx Highlights Integrated Pharma Logistics Strategy for APAC at LogiPharma</title>
			<atom:link href="https://biospectrumasia.com/news/100/27827/fedex-highlights-integrated-pharma-logistics-strategy-for-apac-at-logipharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/100/27827/fedex-highlights-integrated-pharma-logistics-strategy-for-apac-at-logipharma.html</link>
			<pubDate>Wed, 17 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fedex_pharma_cargo-27827.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/100/27827/fedex-highlights-integrated-pharma-logistics-strategy-for-apac-at-logipharma.html</guid>
		</item>	
				<item>
			<title>Rznomics Reports Interim Data for RNA Gene Therapy in Recurrent Glioblastoma</title>
			<atom:link href="https://biospectrumasia.com/news/100/27809/rznomics-reports-interim-data-for-rna-gene-therapy-in-recurrent-glioblastoma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/100/27809/rznomics-reports-interim-data-for-rna-gene-therapy-in-recurrent-glioblastoma.html</link>
			<pubDate>Mon, 15 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images_3_-27809.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/100/27809/rznomics-reports-interim-data-for-rna-gene-therapy-in-recurrent-glioblastoma.html</guid>
		</item>	
				<item>
			<title>CARsgen Presents Allogeneic CAR-T Data for Blood Cancers at EHA 2026</title>
			<atom:link href="https://biospectrumasia.com/news/100/27810/carsgen-presents-allogeneic-car-t-data-for-blood-cancers-at-eha-2026.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/100/27810/carsgen-presents-allogeneic-car-t-data-for-blood-cancers-at-eha-2026.html</link>
			<pubDate>Mon, 15 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/carsgen_1920-27810.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/100/27810/carsgen-presents-allogeneic-car-t-data-for-blood-cancers-at-eha-2026.html</guid>
		</item>	
				<item>
			<title>MaaT Pharma Reports Phase 3 Data for Microbiome Therapy in Acute GvHD</title>
			<atom:link href="https://biospectrumasia.com/news/100/27793/maat-pharma-reports-phase-3-data-for-microbiome-therapy-in-acute-gvhd.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/100/27793/maat-pharma-reports-phase-3-data-for-microbiome-therapy-in-acute-gvhd.html</link>
			<pubDate>Thu, 11 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images-27793.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/100/27793/maat-pharma-reports-phase-3-data-for-microbiome-therapy-in-acute-gvhd.html</guid>
		</item>	
				<item>
			<title>Lilly’s Oral GLP-1 Foundayo Shows Superior Phase III Diabetes Results</title>
			<atom:link href="https://biospectrumasia.com/news/100/27778/lillys-oral-glp-1-foundayo-shows-superior-phase-iii-diabetes-results.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/100/27778/lillys-oral-glp-1-foundayo-shows-superior-phase-iii-diabetes-results.html</link>
			<pubDate>Tue, 09 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/usa_lilly-27778.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/100/27778/lillys-oral-glp-1-foundayo-shows-superior-phase-iii-diabetes-results.html</guid>
		</item>	
				<item>
			<title>CellProthera Prepares For Phase 3 Push As Regenerative Cardiology Moves Closer To Clinical Reality</title>
			<atom:link href="https://biospectrumasia.com/news/100/27723/cellprothera-prepares-for-phase-3-push-as-regenerative-cardiology-moves-closer-to-clinical-reality.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/100/27723/cellprothera-prepares-for-phase-3-push-as-regenerative-cardiology-moves-closer-to-clinical-reality.html</link>
			<pubDate>Mon, 01 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/f04dcfdb_bdae_49b1_b84d_252a6da20c7e-27723.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/100/27723/cellprothera-prepares-for-phase-3-push-as-regenerative-cardiology-moves-closer-to-clinical-reality.html</guid>
		</item>	
				<item>
			<title>Minghui Reports Phase I/II Data for MHB018A in Thyroid Eye Disease</title>
			<atom:link href="https://biospectrumasia.com/news/100/27818/minghui-reports-phase-i-ii-data-for-mhb018a-in-thyroid-eye-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/100/27818/minghui-reports-phase-i-ii-data-for-mhb018a-in-thyroid-eye-disease.html</link>
			<pubDate>Sat, 16 May 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images_5_-27818.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/100/27818/minghui-reports-phase-i-ii-data-for-mhb018a-in-thyroid-eye-disease.html</guid>
		</item>	
				<item>
			<title>Expecto Health Science Partners with Neuratrial to Pioneer AI-Driven CRO Operating Model</title>
			<atom:link href="https://biospectrumasia.com/news/100/27470/expecto-health-science-partners-with-neuratrial-to-pioneer-ai-driven-cro-operating-model.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/100/27470/expecto-health-science-partners-with-neuratrial-to-pioneer-ai-driven-cro-operating-model.html</link>
			<pubDate>Wed, 08 Apr 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/neuratrial_and_expecto_health_sciences_strategic_partnership_-27470.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/100/27470/expecto-health-science-partners-with-neuratrial-to-pioneer-ai-driven-cro-operating-model.html</guid>
		</item>	
				<item>
			<title>Digital Manufacturing Must Lead The Next Phase Of Cell And Gene Therapy Scale Up</title>
			<atom:link href="https://biospectrumasia.com/news/100/27340/digital-manufacturing-must-lead-the-next-phase-of-cell-and-gene-therapy-scale-up.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/100/27340/digital-manufacturing-must-lead-the-next-phase-of-cell-and-gene-therapy-scale-up.html</link>
			<pubDate>Thu, 12 Mar 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/alexander__27242-27340.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/100/27340/digital-manufacturing-must-lead-the-next-phase-of-cell-and-gene-therapy-scale-up.html</guid>
		</item>	
				<item>
			<title>Eli Lilly Commits Over $1.2 Billion to Expand Puerto Rico Manufacturing Hub</title>
			<atom:link href="https://biospectrumasia.com/news/100/26803/eli-lilly-commits-over-1-2-billion-to-expand-puerto-rico-manufacturing-hub.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/100/26803/eli-lilly-commits-over-1-2-billion-to-expand-puerto-rico-manufacturing-hub.html</link>
			<pubDate>Wed, 29 Oct 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/eli_lilly_770x433-26803.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/100/26803/eli-lilly-commits-over-1-2-billion-to-expand-puerto-rico-manufacturing-hub.html</guid>
		</item>	
				<item>
			<title>AI Meets CRO: Expecto Health Science Partners with VertisPro to Overcome Patient Recruitment Challenges</title>
			<atom:link href="https://biospectrumasia.com/news/100/26532/ai-meets-cro-expecto-health-science-partners-with-vertispro-to-overcome-patient-recruitment-challenges.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/100/26532/ai-meets-cro-expecto-health-science-partners-with-vertispro-to-overcome-patient-recruitment-challenges.html</link>
			<pubDate>Mon, 25 Aug 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/expecto_health_science_ubuntu_research_collaborate_to_fast_track_global_biotech_breakthroughs_11zon-26532.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/100/26532/ai-meets-cro-expecto-health-science-partners-with-vertispro-to-overcome-patient-recruitment-challenges.html</guid>
		</item>	
				<item>
			<title>Zhimeng Biopharma begins phase I trial of antiepileptic drug </title>
			<atom:link href="https://biospectrumasia.com/news/100/20281/zhimeng-biopharma-begins-phase-i-trial-of-antiepileptic-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/100/20281/zhimeng-biopharma-begins-phase-i-trial-of-antiepileptic-drug-.html</link>
			<pubDate>Thu, 12 May 2022 14:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/100/20281/zhimeng-biopharma-begins-phase-i-trial-of-antiepileptic-drug-.html</guid>
		</item>	
				<item>
			<title>Korea&#039;s SK bioscience plans Ph III COVID-19 vaccine trial in multiple countries</title>
			<atom:link href="https://biospectrumasia.com/news/100/18792/koreas-sk-bioscience-plans-ph-iii-covid-19-vaccine-trial-in-multiple-countries.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/100/18792/koreas-sk-bioscience-plans-ph-iii-covid-19-vaccine-trial-in-multiple-countries.html</link>
			<pubDate>Wed, 11 Aug 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/freepik3243-18792.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/100/18792/koreas-sk-bioscience-plans-ph-iii-covid-19-vaccine-trial-in-multiple-countries.html</guid>
		</item>	
				<item>
			<title>as</title>
			<atom:link href="https://biospectrumasia.com/opinion/100/18556/as.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/100/18556/as.html</link>
			<pubDate>Fri, 09 Jul 2021 17:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/100/18556/as.html</guid>
		</item>	
				<item>
			<title>China approves first hormone replacement therapy for hypoparathyroidism</title>
			<atom:link href="https://biospectrumasia.com/news/100/18299/china-approves-first-hormone-replacement-therapy-for-hypoparathyroidism.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/100/18299/china-approves-first-hormone-replacement-therapy-for-hypoparathyroidism.html</link>
			<pubDate>Fri, 04 Jun 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/close_up_view_medical_flasks_with_doctor_intern_student_working_laboratory_254969_1697-18299.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/100/18299/china-approves-first-hormone-replacement-therapy-for-hypoparathyroidism.html</guid>
		</item>	
				<item>
			<title>GlobalData reports the status of Global COVID-19 vaccine trials </title>
			<atom:link href="https://biospectrumasia.com/analysis/100/17564/globaldata-reports-the-status-of-global-covid-19-vaccine-trials-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/100/17564/globaldata-reports-the-status-of-global-covid-19-vaccine-trials-.html</link>
			<pubDate>Mon, 08 Feb 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/unnamed-17564.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/100/17564/globaldata-reports-the-status-of-global-covid-19-vaccine-trials-.html</guid>
		</item>	
				<item>
			<title>I-Mab reports efficacy of Anti-CD47 monoclonal Ab on relapsed/refractory malignancy</title>
			<atom:link href="https://biospectrumasia.com/company-results/100/17177/i-mab-reports-efficacy-of-anti-cd47-monoclonal-ab-on-relapsed-refractory-malignancy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/company-results/100/17177/i-mab-reports-efficacy-of-anti-cd47-monoclonal-ab-on-relapsed-refractory-malignancy.html</link>
			<pubDate>Wed, 25 Nov 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cd47_image-17177.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/company-results/100/17177/i-mab-reports-efficacy-of-anti-cd47-monoclonal-ab-on-relapsed-refractory-malignancy.html</guid>
		</item>	
				<item>
			<title>Gilead&#039;s Biktarvy sustains viral suppression and tolerability in Asian HIV patients</title>
			<atom:link href="https://biospectrumasia.com/news/100/16945/gileads-biktarvy-sustains-viral-suppression-and-tolerability-in-asian-hiv-patients.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/100/16945/gileads-biktarvy-sustains-viral-suppression-and-tolerability-in-asian-hiv-patients.html</link>
			<pubDate>Fri, 16 Oct 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pexels_2-16945.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/100/16945/gileads-biktarvy-sustains-viral-suppression-and-tolerability-in-asian-hiv-patients.html</guid>
		</item>	
				</channel>
</rss>
